ClinicalTrials.govpublic full text
Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial
hypertension (htn), sodium-glucose transporter 2 inhibitors, mineralocorticoid receptor antagonists, blood pressure, obesity, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803544
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.